Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Description

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Conditions

Autoimmune Diseases, Cardiovascular Disorders, Diabetes Complications, Integumentary Disease, Musculoskeletal Disorders, Neurodegenerative Disorders, Neurologic Disorders, Pulmonary Disorders, Sexual Dysfunction, Urologic Disorders, Viral Illness

Study Overview

Study Details

Study overview

This multi-arm, multi-site study investigates the safety, tolerability, and efficacy of stem cell therapy for the treatment of various acute and chronic conditions. Clinically observed initial findings and an extensive body of research indicate regenerative treatments are both safe and effective for the treatment of multiple conditions.

Evaluation of the Safety, Tolerability and Efficacy of Regenerative Therapy for the Treatment of Various Chronic and Acute Conditions

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

Condition
Autoimmune Diseases
Intervention / Treatment

-

Contacts and Locations

Culver City

Southern California Hospital at Culver City / Southern California Hospital at Hollywood / Multiple US-based Sub-Investigator Sites, Culver City, California, United States, 92032

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Age 18 and older
  • * Ability to provide informed consent
  • * Availability for follow up visits
  • * Active or recent malignancy (within last 2 years)
  • * Pregnancy or breast-feeding
  • * Inability to provide informed consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Thomas Advanced Medical LLC,

Ernst R Von Schwarz, MD, PhD, PRINCIPAL_INVESTIGATOR, HeartStem Institute, Southern California Hospital at Culver City

Study Record Dates

2030-12-09